GNAI3: Another Candidate Gene to Screen in Persons with Ocular Albinism

Autor: Jie Zheng, Uma Dandekar, Alejandra Young, C. Avery Sader, Calvin Pan, Richard A. Lewis, Debora B. Farber
Přispěvatelé: Lewin, Alfred S
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Models
Molecular

Candidate gene
lcsh:Medicine
GTP-Binding Protein alpha Subunits
Gi-Go

Biochemistry
Gi-Go
Exon
Untranslated Regions
Models
2.1 Biological and endogenous factors
Aetiology
lcsh:Science
3' Untranslated Regions
Base Pairing
Genetics
Sanger sequencing
Multidisciplinary
Messenger RNA
Homozygote
Genomics
Single Nucleotide
Exons
Albinism
Ocular

GTP-Binding Protein alpha Subunits
Nucleic acids
Phenotypes
5' Utr
Albinism
symbols
Ocular albinism type 1
Sequence Analysis
Research Article
Ocular albinism
Heterozygote
General Science & Technology
Biology
Genome Complexity
Research and Analysis Methods
Polymorphism
Single Nucleotide

Frameshift mutation
03 medical and health sciences
symbols.namesake
Sequence Motif Analysis
Ocular
medicine
Humans
Genetic Predisposition to Disease
Polymorphism
Molecular Biology Techniques
Sequencing Techniques
Gene
Molecular Biology
Eye Disease and Disorders of Vision
Genetic Association Studies
030102 biochemistry & molecular biology
Biology and life sciences
Base Sequence
lcsh:R
Neurosciences
Computational Biology
Reproducibility of Results
Molecular
Sequence Analysis
DNA

DNA
medicine.disease
eye diseases
Introns
030104 developmental biology
Genetic Loci
Mutation
RNA
lcsh:Q
sense organs
5' Untranslated Regions
Sequence Alignment
Zdroj: Young, A; Dandekar, U; Pan, C; Sader, A; Zheng, JJ; Lewis, RA; et al.(2016). GNAI3: Another Candidate Gene to Screen in Persons with Ocular Albinism. PLOS ONE, 11(9). doi: 10.1371/journal.pone.0162273. UCLA: Retrieved from: http://www.escholarship.org/uc/item/9hd4r6w4
PloS one, vol 11, iss 9
PLoS ONE, Vol 11, Iss 9, p e0162273 (2016)
PLoS ONE
Popis: Ocular albinism type 1 (OA), caused by mutations in the OA1 gene, encodes a G-protein coupled receptor, OA1, localized in melanosomal membranes of the retinal pigment epithelium (RPE). This disorder is characterized by both RPE macro-melanosomes and abnormal decussation of ganglion cell axons at the brain’s optic chiasm. We demonstrated previously that Oa1 specifically activates Gαi3, which also signals in the Oa1 transduction pathway that regulates melanosomal biogenesis. In this study, we screened the human Gαi3 gene, GNAI3, in DNA samples from 26 patients who had all clinical characteristics of OA but in whom a specific mutation in the OA1 gene had not been found, and in 6 normal control individuals. Using the Agilent HaloPlex Target Enrichment System and next-generation sequencing (NGS) on the Illumina MiSeq platform, we identified 518 variants after rigorous filtering. Many of these variants were corroborated by Sanger sequencing. Overall, 98.8% coverage of the GNAI3 gene was obtained by the HaloPlex amplicons. Of all variants, 6 non-synonymous and 3 synonymous were in exons, 41 in a non-coding exon embedded in the 3’ untranslated region (UTR), 6 in the 5’ UTR, and 462 in introns. These variants included novel SNVs, insertions, deletions, and a frameshift mutation. All were found in at least one patient but none in control samples. Using computational methods, we modeled the GNAI3 protein and its non-synonymous exonic mutations and determined that several of these may be the cause of disease in the patients studied. Thus, we have identified GNAI3 as a second gene possibly responsible for X-linked ocular albinism.
Databáze: OpenAIRE